Employer-Sponsored Health Insurance


KFF has conducted this annual survey of private and non-federal public employers with three or more workers since 1999. The survey tracks trends in employer health insurance coverage, the cost of that coverage, and other topical health insurance issues. Findings are based on a nationally representative survey of public and private employers with three or more employees, including those who respond to the full survey and those who indicate only whether or not they provide health coverage. Browse the reports


Filter

141-150 of 446 results

  • Key Issues Related to COBRA Subsidies

    Issue Brief

    Congress is considering proposals to subsidize COBRA coverage. We discuss the group market coverage that would be extended by COBRA subsidies, how COBRA costs and coverage compare to other common coverage options for those who lose job-based coverage (ACA Marketplace plans or Medicaid), and key considerations regarding COBRA subsidies for consumers and employers.

  • New Analysis Reveals Gaps in Abortion Coverage for Employees with Employer-Sponsored Plans

    News Release

    New analysis of KFF’s 2019 Employer Benefits Survey finds that 10% of workers covered by employer-sponsored health insurance are employed at a firm that has asked their insurer or third party administrator to exclude abortion coverage from their health plan. Employer-sponsored coverage is the primary source of health benefits in the U.S., covering 153 million Americans. Four percent of covered workers are employed at firms that exclude coverage of abortion under any circumstance and 6%…

  • Exclusion of Abortion Coverage from Employer-Sponsored Health Plans

    Issue Brief

    This issue brief presents data from the 2019 KFF Employer Health Benefits Survey on the share of covered workers who are employed by firms that have asked their insurer or third party administrator to exclude coverage for abortion from their health plan.

  • Potential Costs of Coronavirus Treatment for People with Employer Coverage

    Issue Brief

    As COVID-19 spreads within the United States, questions have arisen over the potential costs people may face if they become severely ill and need treatment. While many large insurers have agreed to waive copayments and deductibles for COVID-19 tests, people with private insurance who face deductibles could still be on the hook for large treatment costs. A new brief examines the potential cost of COVID-19 treatment to employer health plans and their enrollees by looking…

  • New Analysis Finds Inpatient Coronavirus Treatment Costs Could Top $20K for Patients with Employer Coverage

    News Release

    A new issue brief estimates potential coronavirus treatment costs to large employer health plans and their enrollees by looking at typical spending for hospital admissions for pneumonia. The analysis finds that, for pneumonia admissions with major complications and comorbidities, the average total cost is $20,292. In comparison, the average cost for a patient with no complications or comorbidities is $9,763. Average out-of-pocket costs could exceed $1,300 for all admitted patients, including those without complications or…